Researchers are exploring ways to overcome tumor resistance in car-t-cell therapy, with studies focusing on various aspects such as unlocking apoptotic pathways and enhancing cell persistence. Different types of cancer, including pancreatic ductal adenocarcinoma, breast cancer, and gastric cancer, are being investigated to develop targeted interventions. The approaches being considered include novel strategies, synthetic biology, and integrating molecular insights to improve the efficacy of cancer immunotherapy.